Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
28.13 EUR
2.85%
Market Closed
Updated:
May 3, 2024
Bayer AG
Accounts Receivables
|
Bayer AG
Accounts Receivables Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Accounts Receivables
€9.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Accounts Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Accounts Receivables
€4.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Accounts Receivables
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Accounts Receivables
€90.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Accounts Receivables
€7.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Accounts Receivables?
Accounts Receivables
9.3B
EUR
9.3B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Accounts Receivables amounts to 9.3B EUR.
What is Bayer AG's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
2%
2%
Over the last year, the Accounts Receivables growth was -9%. The average annual Accounts Receivables growth rates for Bayer AG have been -1% over the past three years , -4% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
